Exchange: NYSE Sector: Healthcare Industry: Chemicals
Current Signal: SELL (auto-tracking)
-5.91% $3.50
America/New_York / 6 mai 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 171.23 mill |
EPS: | -0.490 |
P/E: | -7.14 |
Earnings Date: | May 17, 2024 |
SharesOutstanding: | 48.92 mill |
Avg Daily Volume: | 0.657 mill |
RATING 2024-05-06 |
---|
B- |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Sell | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Neutral | |
P/E: | Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -7.14 | sector: PE 15.43 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.96x |
Company: PE -7.14 | industry: PE 7.40 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 3.08 - 3.92 ( +/- 11.89%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-30 | Ryan Robert John Andrew | Buy | 7 500 | Common Stock |
2024-04-30 | Ryan Robert John Andrew | Buy | 5 000 | Common Stock |
2024-04-30 | Ryan Robert John Andrew | Buy | 3 734 | Common Stock |
2024-04-29 | Ryan Robert John Andrew | Buy | 4 313 | Common Stock |
2024-04-26 | Ryan Robert John Andrew | Buy | 5 000 | Common Stock |
INSIDER POWER |
---|
73.19 |
Last 47 transactions |
Buy: 6 694 530 | Sell: 1 423 000 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $3.50 (-5.91% ) |
Volume | 0.451 mill |
Avg. Vol. | 0.657 mill |
% of Avg. Vol | 68.59 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 6 - 10:41 | buy | $3.04 | N/A | Active |
---|